enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.66M | 1.72M | 1.95M | 2.40M | 2.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.53M | 3.80M | 4.06M | 4.35M | 5.17M |
| Operating Income | -4.53M | -3.80M | -4.06M | -4.35M | -5.17M |
| Income Before Tax | -4.37M | -3.60M | -3.85M | -3.74M | -4.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.37M | -3.60M | -3.85M | -3.74M | -4.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.37M | -3.60M | -3.85M | -3.74M | -4.54M |
| EBIT | -4.53M | -3.80M | -4.06M | -4.35M | -5.17M |
| EBITDA | -4.52M | -3.77M | -4.03M | -4.32M | -5.14M |
| EPS Basic | -6.29 | -5.37 | -5.89 | -6.05 | -7.89 |
| Normalized Basic EPS | -4.07 | -3.53 | -3.86 | -4.30 | -5.43 |
| EPS Diluted | -6.29 | -5.37 | -5.89 | -6.05 | -7.89 |
| Normalized Diluted EPS | -4.07 | -3.53 | -3.86 | -4.30 | -5.43 |
| Average Basic Shares Outstanding | 694.00K | 671.00K | 654.00K | 617.20K | 575.00K |
| Average Diluted Shares Outstanding | 694.00K | 671.00K | 654.00K | 617.20K | 575.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |